Skip to main content Back to Top

3/3/2004
Press Release

ASHP Offers the Gold Standard in Drug Information for Health Professionals

Pharmacists and other health care professionals who need quick access to drug information to ensure the safety of their patients will find a wealth of resources in the American Society of Health-System Pharmacists’ (ASHP’s) family of drug information references, including the new 2004 print edition of AHFS Drug Information (AHFS DI). 

AHFS DI is the most comprehensive source of unbiased and authoritative drug information available to health professionals today. It is available as a suite of products, including the print edition, which has been a highly respected reference used in hospitals since 1959. The 2004 edition incorporates important new clinical guidelines and has added nearly 100 new medication subclasses to help health care professionals locate drug monographs on therapeutically similar drugs even faster than before.

A wholly independent staff of drug information pharmacists and other professional editorial and analytical staff thoroughly research AHFS DI content. Authors incorporate clinical research findings, therapeutic guidelines, and Food and Drug Administration (FDA) approved labeling to ensure that monographs include an evidence-based foundation for safe and effective drug therapy. 

The clinical perspectives and advice from a panel of more than 500 medication experts, including leading medical scientists, physicians, pharmacists, pharmacologists, and other clinicians also are incorporated in the monographs.  These experts provide a complete disclosure of interest as a condition of participation in this review process. 

New AHFS DI features demonstrate ASHP’s strong, longstanding commitment to patient safety, including:

  • The elimination of all dangerous abbreviations and symbols identified by the Joint Commission on Accreditation of Healthcare Organizations’ 2004 National Patient Safety Goals,
  • Monograph updates that reflect therapeutic guidelines from the:
    • U.S. Centers for Disease Control and Prevention,
    • Joint National Committee (JNC 7) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,
    • Institute of Medicine of the National Academies,
    • American Heart Association,
    • Women’s Health Initiative,
    • National Institutes of Health, and many others,
  • And, the addition of major cautionary information from FDA MedWatch notices, as well as new scientific findings from a variety of authoritative sources.

“This new edition of AHFS DI demonstrates ASHP’s deep commitment to providing the most comprehensive, accurate, and independent drug information resources to health care professionals,” said Gerald McEvoy, Pharm. D., ASHP assistant vice president of drug information and editor, AHFS DI. “We believe patient safety depends on accurate and up-to-date drug information.”

The U.S. Congress, the Centers for Medicare and Medicaid Services, and various health care insurance providers have recognized the authority of the AHFS DI suite of products as a source of information on the medically accepted uses of drugs. Both the National Association of Boards of Pharmacy and the American College of Physicians-American Society of Internal Medicine have listed AHFS DI as a standard item for inclusion in reference libraries.

The AHFS DI product line also includes an Intranet/Internet deployable knowledge base (AHFSfirstWeb™) and multimedia memory cards (AHFS ® for PDAs). The AHFS DI database is included in the STAT!Ref electronic medical library and AHFS DI  also provides detailed drug information to complement the ePocrates drug reference guide in ePocrates Rx Online(TM) + AHFS® DI, an Internet-based formulary management product for hospitals.

AHFS DI subscribers can access continual database updates at www.ahfsdruginformation.com, which provides the most current developments, updates, recalls, and warnings related to drug therapies. Subscribers to the ASHPaccess™ service can download AHFS DI information from the Web onto a personal digital assistant and customize the data to meet individual practice needs.

For more information on AHFS Drug Information or any other items in the AHFS product line, call ASHP Customer Service at (301) 657-4383 or visit the Society’s drug information Web site at www.ahfsdruginformation.com.

ASHP is the 30,000-member national professional association that represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care, and other components of health care systems. ASHP, which has a long history of medication-error prevention efforts, believes that the mission of pharmacists is to help people make the best use of medicines.  Assisting pharmacists in fulfilling this mission is ASHP’s primary objective.  The Society has extensive publishing and educational programs designed to help members improve their professional practice, and it is the national accrediting organization for pharmacy residency and pharmacy technician training programs. For more information, visit www.ashp.org or www.SafeMedication.com.